Advertisement

Antares Pharma, Inc. ATRS

Set alert

Price alert · ATRS

All alert types
5.59 +5.59 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
955.06M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
25.41
Beta
1.15
Short ratio
0.41
Inst. own
62.83%
Dividend
0.00
Ex-div date
Earnings
May 10, 2022
50-d avg
4.90
200-d avg
3.92
1y target
5.95

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ATRS has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue by
Income Tax Benefit → Expenses: $817.00KProduct → Revenue: $32.10MExpenses → Selling, General & Admin: $20.60MExpenses → Research & Development: $5.01MExpenses → Interest Expense: $174.00KExpenses → Other Expenses: $144.00KGross Profit → Expenses: $22.79MRevenue → Gross Profit: $22.79MRevenue → Cost of Revenue: $18.77MNet Loss → Expenses: $2.32MRoyalty → Revenue: $5.26MLicensing And Development Revenue → Revenue: $4.19MIncome Tax Benefit$817.00KGross Profit$22.79MNet Loss$2.32MCost of Revenue$18.77MExpenses$25.93MSelling, General & Admin$20.60MResearch & Development$5.01MInterest Expense$174.00KOther Expenses$144.00KRevenue$41.56MProduct$32.10MRoyalty$5.26MLicensing And Development Revenue$4.19M

Period ending Mar 31, 2022 · select a line to chart its history

Income statement

ATRS quarterly income statement
41.56M
41.56M
15.65M
25.91M
25.61M
5.01M
20.60M
299.00K
174.00K
-817.00K
-2.32M
-2.32M
-2.32M
-2.32M
-0.01
-0.01
-0.01
-2.96M
-2.96M
170.10M
170.10M

Balance sheet

ATRS quarterly balance sheet
61.72M
61.72M
498.00K
498.00K
84.14M
171.59M
30.23M
255.66M
2.54M
25.49M
55.73M
22.95M
79.89M
-178.66M
-686.00K
175.77M
175.77M
84.07M
25.49M
4.31M
18.79M
11.59M
24.16M
19.88M
33.86M

Cash flow

ATRS quarterly cash flow
931.00K
17.00K
-4.20M
-81.00K
913.00K
-375.00K
666.00K
747.00K
-4.88M
1.94M
Advertisement